Levothyroxine sodium 25microgram capsules
BNF presentation 0602010V0AAAGAG within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0602010V0AAAGAG
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
331
NHS spend (£)
£38,847.25
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 69 |
| December 2024 | 23 |
| November 2024 | 64 |
| October 2024 | 69 |
| August 2024 | 5 |
| July 2024 | 62 |
| May 2024 | 13 |
| July 2021 | 7 |
| December 2020 | 8 |
| November 2020 | 11 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 11 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |